Cancer is complex and dynamic—ergo, dose optimization calls for mathematical modeling – The Cancer Letter

The Cancer Letter
Inside information on cancer research and drug development
The Cancer Letter
Inside information on cancer research and drug development
We wish to applaud the sentiments expressed in the recent article in The Cancer Letter titled “Oncologists, advocates, FDA call for an end to MTD and ‘more is better’ era in cancer drug dosing,” but also raise several concerns to be addressed as this initiative moves forward. 
SITC opens calls for nominations for 2022 Steven A. Rosenberg Scholars Award
ACCC establishes projects to address cancer screening and care challenges in Appalachia
Only fill in if you are not human
Looking for IP Login?
This change will be effective immediately and your card will be charged a prorated amount based on your existing subscription level.
OK Cancel
Looking for IP Login?

source